Valuation : Ipca Laboratories Limited

Market Cap 496B 5.25B 4.52B 4.24B 3.88B 7.24B 7.3B 50.14B 19.53B 254B 19.71B 19.28B 817B P/E 2027 *
32.7x
P/E 2028 * 28x
Enterprise Value 486B 5.14B 4.42B 4.15B 3.79B 7.08B 7.14B 49.07B 19.11B 248B 19.29B 18.87B 799B EV / Sales 2027 *
4.42x
EV / Sales 2028 * 3.88x
Free-Float
54.94%
Yield 2027 *
0.29%
Yield 2028 * 0.32%
1 day-0.06%
1 week-0.18%
Current month-1.01%
1 month+13.46%
3 months+25.80%
6 months+32.45%
Current year+37.30%
1 week 1,907.6
Extreme 1907.6
1,999
1 month 1,645.9
Extreme 1645.9
1,999
Current year 1,392
Extreme 1392
1,999
1 year 1,252.95
Extreme 1252.95
1,999
3 years 857.5
Extreme 857.5
1,999
5 years 670
Extreme 670
1,999
10 years 200
Extreme 200
1,999
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-31
Chief Executive Officer 70 2023-03-31
Chief Tech/Sci/R&D Officer 52 2023-10-15
Director TitleAgeSince
Chairman 79 2012-07-04
Director/Board Member 53 2008-11-10
Director/Board Member 70 1994-07-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.06%-0.18% - - 5.25B
-0.26%-1.93%+56.33%+106.64% 1,034B
+1.04%+4.65%+56.26%+73.10% 663B
-0.31%+0.96%+23.02%+78.38% 462B
+2.09%-2.06%+32.28%+38.37% 344B
0.00%+5.36%+27.40%+47.50% 307B
+1.42%+0.26%-0.52%+13.62% 251B
+0.17%+1.59%+56.40%+74.77% 239B
-0.03%+2.13%-17.30%-53.99% 207B
+0.32%+0.94%+32.99%+99.93% 186B
Average +0.58%-0.70%+29.65%+53.15% 410.37B
Weighted average by Cap. +0.53%-0.84%+38.35%+68.09%

Financials

2027 *2028 *
Net sales 110B 1.16B 1B 939M 859M 1.6B 1.62B 11.11B 4.33B 56.19B 4.37B 4.27B 181B 123B 1.3B 1.12B 1.05B 959M 1.79B 1.8B 12.39B 4.83B 62.68B 4.87B 4.77B 202B
Net income 15.15B 160M 138M 129M 118M 221M 223M 1.53B 596M 7.74B 602M 589M 24.93B 17.8B 188M 162M 152M 139M 260M 262M 1.8B 700M 9.09B 707M 692M 29.29B
Net Debt -10.65B -113M -96.93M -90.96M -83.23M -155M -157M -1.08B -419M -5.44B -423M -414M -17.53B -19.96B -211M -182M -170M -156M -291M -293M -2.02B -785M -10.2B -793M -775M -32.85B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
26-09-03 1,955.20 -0.06% 46,969
26-09-02 ₹1,956.35 -1.49% 94,267
26-09-01 ₹1,985.95 +0.55% 18,853
26-08-31 ₹1,975.10 +1.25% 14,770
26-08-28 ₹1,950.75 -0.40% 13,038
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,956.10INR
Average target price
1,972.28INR
Spread / Average Target
+0.83%

Quarterly revenue - Rate of surprise